Day 1 – Thursday 15th June 2023
Keynote Address
Dengue: Past, Present and Future
Prof. Usa Thisyakorn
Plenary 1:
Road Map to Zero Dengue Death
Dr. Jurai Wongsawat
Plenary 2:
Adult Dengue
Prof. Terapong Tantawichien
Symposium 1: Dengue Epidemiology
Global Epidemiology
Adult Dengue
Prof. Richard Maude
Dengue in ASEAN Community
Dr. Anggraini Alam
What Will it Take to Drive Dengue Incidence to Zero
Prof. Duane J Gubler
Industry Symposium 1: Takeda Pharmaceuticals TAK-003 From Vaccine to Vaccination Reality
A Balanced Immunity?
Prof. Ooi Eng Eong
Learnings from TAK-003 Implementation
Prof. Sri Rezeki S Hadinegoro
Dengue vaccine:
Prof. Nakorn Premsri
Symposium 3: Clinical Features of Dengue Patients
Dengue in Pregnancy
Assoc. Prof. Surasith Chaithongwongwatthana
Dengue: From Childhood to Elderly
Prof. Terapong Tantawichien
Dengue in ICU setting
Prof. Nattachai Srisawat
Symposium 5: Organopathy in Dengue Patients
Kidney complications
Assoc. Prof. Weerapong Phumratanaprapin
Liver Complications in Dengue Patients
Dr. Chalermrat Bunchorntavakul
DENGUE and NERVOUS SYSTEM
Prof. Thiravat Hemachudha
Cardiovascular Changes in Dengue Virus Infection:
Prof. Apichai Khongphatthanayothin
Day 2 – Friday 16th June 2023
Plenary 3:
Severe Dengue
Prof. Nattachai Srisawat
Plenary 4:
Environmental Influence on Dengue
Assoc. Prof. Pratap
Singhasivanondh
Plenary 5:
World Dengue Day: A Call for Action
Mr. Kamran Rafiq
Oral Presentation:
EFFICACY AND SAFETY OF BUTANTAN-DV LIVE-ATTENUATED TETRAVALENT DENGUE VACCINE OVER TWO YEARS IN A PHASE 3 CLINICAL TRIAL
Monica AT Cintra
Symposium 7: Dengue in Special Hosts
Dengue in Patients with Medical Comorbid Conditions
Prof. Terapong Tantawichien
WHO Case Classification for Dengue
Prof. Lucy CS Lum
Symposium 8: Dengue Vector Control
DENGUE VECTOR CONTROL: ASSESSING WHAT WORKS?
Dr. Jirod Nararak
Dengue Vector Control: Assessing What Works in Thailand
Dr. Piti Mongkalangoon
The World Mosquito Program’s Wolbachia Success Stories
Eggi Arguni
The World Mosquito Programe’s Wolbachia Success Stories
Dr. Nadege Rossi
Social Awareness and Capacity Building
Dr. Fatima Gimenez
Industry Symposium 3: Johnson & Johnson
Promises and challenges with dengue vaccines
Dr. Lulu Bravo
The Role of Asymptomatic Infection in Dengue Transmission Dynamics
Prof. Martin Hibberd
Antiviral activity, safety, and pharmacokinetics of JNJ‑1802 as pre-exposure prophylaxis against attenuated DENV-3 in a human challenge model
Dr. Freya Rasschaert
Deployment of antivirals as a tool for outbreak control in endemic communities
Prof. Martin Hibberd
Industry Symposium 4: Fujifilm
Amplifying Accuracy with High Sensitivity Detection:
Nattachai Srisawat
Burden of dengue in the Philippines
Michelle Ylade
Symposium 9: Management of Dengue Patients
Updates in Clinical Management of Dengue
Prof. Muhammad Ashraf Sultan
Dengue therapeutics and need for a global platform trial
Sophie Yacoub
Psychosocial Impact of Dengue Infection in Adolescents
Vitharon Boon-yasidhi
Symposium 10: Arboviruses Vaccines
Dengue Vaccine from Bench to Community
Maria Rosario Z. Capeding
VACCINE HESITANCY
Prof. Dr Iqbal Ahmad Memon
Finale: Way Forward
Dengue Task Force and Young ADVA
The Next Generation of Dengue Advocates
Mr. Dafydd Green
Dengue : A Global Threat
Ms. Radanut Bawarntanaoran
Dengue Awareness Campaign
Ms. Apinporn Tungthirasuk
Prevention and Control: Partnership and Networking
Ms. Chomphunuch Thaweeaphiradeethongkam